{"id":3643,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1961-05-15","marketCap":17957.6,"name":"Baxter International Inc","phone":"18479482000","outstanding":509.35,"symbol":"BAX","website":"https://www.baxter.com/","industry":"Health Care"},"price":33.955,"year":2024,"month":5,"day":24,"weekday":"Friday","title":"Relationship between Baxter International Inc stock's performance and dividend history","date":"2024-05-24","url":"/posts/2024/05/24/BAX","content":[{"section":"Dividend History","text":"Baxter International Inc has a consistent history of paying dividends to its shareholders. Over the years, it has regularly declared and paid dividends, reflecting the company's commitment to returning value to its investors."},{"section":"Dividend Yield","text":"The dividend yield is calculated by dividing the annual dividend payment by the stock's current price. It represents the percentage return an investor receives on their investment through dividends. By analyzing Baxter International Inc's dividend yield, we can observe its relationship with the stock's performance."},{"section":"Positive Dividend Yield Impact","text":"In general, investors tend to associate higher dividend yields with more attractive investment opportunities. When the dividend yield of Baxter International Inc increases, it may attract dividend-seeking investors, leading to an increase in demand for the stock. This increased demand can positively impact the stock's performance and potentially drive up its price."},{"section":"Dividend Stability","text":"The stability of Baxter International Inc's dividend payments is an important factor to consider. A company that consistently pays dividends, maintains or increases them over time, demonstrates financial stability and confidence in its future prospects. This stability can attract long-term investors and contribute to the stock's overall performance."},{"section":"Dividend Growth","text":"Another aspect to analyze is the growth rate of Baxter International Inc's dividends. Companies that consistently increase their dividends signal their ability to generate sufficient cash flow and profitability. As a result, dividend growth can positively influence the stock's performance by attracting income-oriented investors who seek increasing income streams."},{"section":"Market Perception","text":"The market's perception of Baxter International Inc's dividend history can also impact the stock's performance. If shareholders perceive the dividend payments as consistent, reliable, and well-managed, it can contribute to a positive sentiment surrounding the stock. This positive sentiment can drive demand and potentially boost the stock's performance."},{"section":"Caution for Exaggerated Claims","text":"It is important to avoid making exaggerated claims about the impact of dividends on Baxter International Inc's stock performance. While dividends can influence the stock's performance, they are just one of many factors that investors consider when making investment decisions. Other factors like the company's financial health, market conditions, and industry trends also play significant roles."},{"section":"Conclusion","text":"Baxter International Inc's dividend history can have a relationship with its stock's performance. A consistent dividend payment, attractive dividend yield, stable dividends, dividend growth, and positive market perception can contribute to a favorable impact on the stock's performance. However, it is crucial to consider dividends as part of a broader analysis and avoid exaggerating their significance."}],"tags":["OverSold","Long","Health Care"],"news":[{"category":"company","date":1716495300,"headline":"Baxter to Present at Jefferies 2024 Global Healthcare Conference","id":127880874,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"BAX","publisher":"Yahoo","summary":"DEERFIELD, Ill., May 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024.","url":"https://finance.yahoo.com/news/baxter-present-jefferies-2024-global-201500165.html"},{"category":"company","date":1716352740,"headline":"Baxter price target lowered by $6 at Citi, here's why","id":127853511,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507061216"},{"category":"company","date":1716277320,"headline":"Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month","id":127814934,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505517986"},{"category":"company","date":1715948100,"headline":"Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers","id":127758307,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500756086"},{"category":"company","date":1715939220,"headline":"BAX July 19th Options Begin Trading","id":127763695,"image":"","symbol":"BAX","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500575210"},{"category":"company","date":1715938500,"headline":"Baxter put volume heavy and directionally bearish","id":127763696,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500561441"},{"category":"company","date":1715833140,"headline":"Baxter International Inc. stock underperforms Thursday when compared to competitors","id":127763697,"image":"","symbol":"BAX","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499355719"},{"category":"company","date":1715824560,"headline":"BAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE","id":127724287,"image":"https://media.zenfs.com/en/prnewswire.com/8c384d51618f9654dd724a3b2ef955fb","symbol":"BAX","publisher":"Yahoo","summary":"Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive.","url":"https://finance.yahoo.com/news/baxter-announces-mission-logo-proposed-015600397.html"},{"category":"company","date":1715734980,"headline":"Baxter says Vantive separation expected in second half of 2024","id":127715557,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497149306"},{"category":"company","date":1715703660,"headline":"Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication","id":127684870,"image":"https://media.zenfs.com/en/zacks.com/b35c1538fbd501bfb8e20b349661fde7","symbol":"BAX","publisher":"Yahoo","summary":"Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.","url":"https://finance.yahoo.com/news/baxters-bax-clinolipid-gets-fdas-162100231.html"},{"category":"company","date":1715677200,"headline":"Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida","id":127684817,"image":"","symbol":"BAX","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=9olk6yy4fb"},{"category":"company","date":1715604300,"headline":"Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication","id":127661369,"image":"https://media.zenfs.com/en/business-wire.com/ec6b8a80b7e287988b0f44e3399a8fe4","symbol":"BAX","publisher":"Yahoo","summary":"DEERFIELD, Ill., May 13, 2024--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insuffici","url":"https://finance.yahoo.com/news/baxter-secures-fda-approval-clinolipid-124500672.html"},{"category":"company","date":1715599620,"headline":"Baxter's Clinolipid gets FDA approval for use in infants","id":127684818,"image":"","symbol":"BAX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493189228"},{"category":"company","date":1715588220,"headline":"(BAX) - Analyzing Baxter Intl's Short Interest","id":127658043,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492921506"},{"category":"company","date":1715586900,"headline":"FDA  approves Baxter's Clinolipid neonatal and pediatric Iindication","id":127658044,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492891701"},{"category":"company","date":1715430853,"headline":"Baxter International's (NYSE:BAX) Dividend Will Be $0.29","id":127637845,"image":"https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","symbol":"BAX","publisher":"Yahoo","summary":"Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 1st of July. This means the annual payment...","url":"https://finance.yahoo.com/news/baxter-internationals-nyse-bax-dividend-123413416.html"},{"category":"company","date":1715426340,"headline":"U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact","id":127637473,"image":"","symbol":"BAX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3491053981"},{"category":"company","date":1715341500,"headline":"Baxter downgraded to hold by TD Cowen in wake of selloff","id":127608717,"image":"","symbol":"BAX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3489291056"},{"category":"company","date":1715331000,"headline":"Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls","id":127608085,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3489021539"},{"category":"company","date":1715315580,"headline":"Baxter just downgraded at TD Cowen, here's why","id":127608719,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3488726428"},{"category":"company","date":1715313840,"headline":"A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts","id":127637474,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3489737551"}]}